Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Other Non-Current Assets: 2023-2024

Historic Other Non-Current Assets for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $6.8 million.

  • Inhibrx Biosciences' Other Non-Current Assets fell 14.51% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 14.51%. This contributed to the annual value of $6.8 million for FY2024, which is 115.90% up from last year.
  • Inhibrx Biosciences' Other Non-Current Assets amounted to $6.8 million in FY2024, which was up 115.90% from $3.2 million recorded in FY2023.
  • In the past 5 years, Inhibrx Biosciences' Other Non-Current Assets registered a high of $6.8 million during FY2024, and its lowest value of $3.2 million during FY2023.
  • Moreover, its 2-year median value for Other Non-Current Assets was $5.0 million (2023), whereas its average is $5.0 million.
  • Data for Inhibrx Biosciences' Other Non-Current Assets shows a peak YoY skyrocketed of 115.90% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Other Non-Current Assets stood at $3.2 million in 2023, then skyrocketed by 115.90% to $6.8 million in 2024.